Vijaya Yezdani
Family Medicine · New Castle, DENPI 1699747386
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $466, 2.2 times the $208 reported in 2019.
Across 150 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$405
- Merck$388
- Exact Sciences$312
- Novo Nordisk$208
- Abbott$176
- Bayer$175
- plus $1K from 30 others
What the payments were for
- Food & beverage$2,701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $405 |
| Merck | 22 | $388 |
| Exact Sciences | 15 | $312 |
| Novo Nordisk | 11 | $208 |
| Abbott | 9 | $176 |
| Bayer | 8 | $175 |
| Johnson & Johnson | 8 | $126 |
| GSK | 7 | $114 |
| Lilly USA, LLC | 5 | $94 |
| VBI Vaccine (delaware) Inc. | 2 | $52 |
| Amgen | 3 | $49 |
| Pfizer | 3 | $49 |
| Sanofi Pasteur Inc. | 2 | $46 |
| Neurocrine Biosciences, Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| Eisai Inc. | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $27 |
| Alkermes, Inc. | 2 | $27 |
| Dexcom, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| AbbVie | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
How this compares
$2,701 in reported general payments places this provider in the 80th percentile of 352 family medicine providers in Delaware.
Other family medicine in New Castle
- Gregory PapaNew Castle$67K
- Khaja YezdaniNew Castle$7K
- Sarah MullinsWilmington$36K
- Ashley PanichelliWilmington$27K
- Michelle PapaNewark$23K
- Maryann ConnorWilmington$21K
- Jill MackeyWilmington$20K
- Wayne TuckerBear$20K
- Ian MyersNewark$17K
- Glenn HamiltonWilmington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.